Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Rhabdomyosarcoma × Idarubicin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 70 Leukemia 40 Precursor Cell Lymphoblastic Leukemia-Lymphoma 16 Leukemia, Myelomonocytic, Acute 16 Leukemia, Monocytic, Acute 16 Leukemia, Megakaryoblastic, Acute 14 Leukemia, Erythroblastic, Acute 14 Congenital Abnormalities 14 Myelodysplastic Syndromes 10 Leukemia, Promyelocytic, Acute 7 Leukemia, Myelomonocytic, Chronic 7 Anemia, Refractory, with Excess of Blasts 7 Recurrence 6 Myeloproliferative Disorders 5 Leukemia, Eosinophilic, Acute 5 Leukemia, Basophilic, Acute 4 Leukemia, Myeloid, Chronic-Phase 3 Blast Crisis 3 Neutropenia 2 Neoplasms 2 Lymphoma 2 Leukemia, Myeloid, Accelerated Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Carcinoma, Hepatocellular 2 Thrombocythemia, Essential 1 Sarcoma, Synovial 1 Sarcoma 1 Rhabdomyosarcoma 1 Primary Myelofibrosis 1 Polycythemia Vera 1

Interventions

Irinotecan 13 Cyclophosphamide 11 Vincristine 10 Radiotherapy 9 Filgrastim 9 Ifosfamide 8 Doxorubicin 8 Dactinomycin 7 Granulocyte Colony-Stimulating Factor 6 Etoposide 6 cixutumumab 5 Sirolimus 5 Melphalan 5 pegfilgrastim 4 Topotecan 4 Temozolomide 4 Radiation 4 Busulfan 4 temsirolimus 3 sargramostim 3 Peripheral Blood Stem Cell Transplantation 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Gemcitabine 3 trioctyl phosphine oxide 2 regorafenib 2 olaparib 2 etoposide phosphate 2 eribulin 2 abemaciclib 2 Trabectedin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00876031 2022-11-08

CWS-2007-HR

University Hospital Tuebingen

Phase 3 Completed

Rhabdomyosarcoma, Sarcoma, Sarcoma, Synovial

Data powered by HemOnc (CC BY 4.0) Colophon ⚡